Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lepirudin vs. Heparin Flushes for VAD Occlusion Prevention
NCT00039767Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- May 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lepirudin in thrombosis, sponsored by National Institutes of Health. Started May 2002; status: completed.
02
Drugs
lepirudin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT00039767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039767.